Skip to main content
. 2022 Feb 23;37(16):4168–4175. doi: 10.1007/s11606-022-07433-4

Table 1.

Sociodemographic Characteristics of California Patients Receiving Medicaid-Funded Long-Acting Contraceptive Procedures, 2008–2014

Levonorgestrel IUC (n= 35,705) Copper IUC (n= 23,628) Tubal ligation (n= 23,965)
Age, years 26.53 ± 6.51 27.24 ± 6.61 32.8 ± 6.7
Age category
18–27 years 64.55 58.70 23.54
28–33 years 21.18 23.43 33.61
34–44 years 12.59 16.56 37.33
45–50 years 1.68 1.32 5.52
Race-ethnicity
White, non-Hispanic 27.50 21.42 31.32
Black, non-Hispanic 10.65 7.41 8.25
Hispanic 48.29 54.17 50.04
Asian 4.63 7.10 3.33
Other* 8.93 9.90 7.05
Region of residence
Northern/Sierra 4.30 2.74 8.11
Sacramento Area 11.92 7.00 8.96
San Joaquin Valley 27.57 24.86 23.28
Greater Bay Area 18.89 16.48 7.53
Central Coast 4.67 4.15 5.50
Los Angeles 11.98 23.06 18.04
Southern California outside Los Angeles 20.68 21.71 28.57
Medi-Cal Program covering procedure
Fee for service 5.92 5.95 10.93
Managed care 94.08 94.05 89.07
Year of index procedure
2008 16.94 18.52 16.30
2009 16.85 16.43 15.30
2010 12.84 16.62 15.23
2011 14.45 14.39 14.70
2012 16.19 12.47 13.23
2013 13.19 12.31 14.00
2014 9.55 9.25 11.24
Endometrial ablation n < 11 n < 11 2.41
Months of Medi-Cal enrollment after procedure 32.84 ± 21.41 34.31 ± 21.89 33.57 ± 21.91

Excluding procedures performed within 42 days of a birth. Table presents column percentages or mean ± standard deviation. P < 0.001 for all comparisons across columns

*Native American/Hawaiian, Pacific Islander, multi-race, unknown

Through 8/31/2014

Within 7 days of contraceptive procedure; CMS policy advises limiting detail on cells with n < 11